DANIA JEAN-LOUIS: Open Payments
NPI 1588187579 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,217 in 83 payments from 15 companies in 2025. Trend: 2023 $125 · 2024 $344 · 2025 $2,217
Food & beverage: $2,217
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $751 |
| Axsome Therapeutics, Inc. | 13 | $448 |
| Otsuka America Pharmaceutical, Inc. | 3 | $264 |
| Vanda Pharmaceuticals Inc. | 9 | $233 |
| Supernus Pharmaceuticals, Inc. | 9 | $230 |
| E.R. Squibb & Sons, L.L.C. | 5 | $81 |
| Teva Pharmaceuticals USA, Inc. | 4 | $70 |
| Exact Sciences Corporation | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: VRAYLAR, Auvelity, Qelbree, REXULTI, FANAPT, ABILIFY MAINTENA, HETLIOZ, COBENFY.
Industry payments across NJ — which companies pay providers there.
